FDA issues warning letters to dietary supplement firms in Colorado and Texas for promoting unapprove
date:Sep 10, 2012
uct quality problems, therapeutic inequivalence/failure, and product use errors with human medical products, including drugs, biologic products, medical devices, dietary supplements, infant formula, and cosmetics. Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Online:www.fda.gov/medwatch/report.htm
Regular Mail: use postage-paid, pre-addressed Form

05/02 07:49